Failure to initiate early insulin therapy - A risk factor for diabetic retinopathy in insulin users with Type 2 diabetes mellitus: Sankara Nethralaya-Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS, Report number 35)
Authors:
Open Access
- 1 January 2016
- journal article
- research article
- Published by Medknow in Indian Journal Of Ophthalmology
- Vol. 64 (6) , 440-5
Abstract
Context: Insulin users have been reported to have a higher incidence of diabetic retinopathy (DR). Aim: The aim was to elucidate the factors associated with DR among insulin users, especially association between duration, prior to initiating insulin for Type 2 diabetes mellitus (DM) and developing DR. Materials and Methods: Retrospective cross-sectional observational study included 1414 subjects having Type 2 DM. Insulin users were defined as subjects using insulin for glycemic control, and insulin nonusers as those either not using any antidiabetic treatment or using diet control or oral medications. The duration before initiating insulin after diagnosis was calculated by subtracting the duration of insulin usage from the duration of DM. DR was clinically graded using Klein's classification. SPSS (version 9.0) was used for statistical analysis. Results: Insulin users had more incidence of DR (52.9% vs. 16.3%, P < 0.0001) and sight threatening DR (19.1% vs. 2.4%, P < 0.0001) in comparison to insulin nonusers. Among insulin users, longer duration of DM (odds ratio [OR] 1.12, 95% confidence interval [CI] 1.00-1.25, P = 0.044) and abdominal obesity (OR 1.15, 95% CI 1.02-1.29, P = 0.021) was associated with DR. The presence of DR was significantly associated with longer duration (≥5 years) prior to initiating insulin therapy, overall (38.0% vs. 62.0%, P = 0.013), and in subjects with suboptimal glycemic control (32.5% vs. 67.5%, P = 0.022). Conclusions: The presence of DR is significantly associated with longer duration of diabetes (>5 years) and sub-optimal glycemic control (glycosylated hemoglobin <7.0%). Among insulin users, abdominal obesity was found to be a significant predictor of DR; DR is associated with longer duration prior to initiating insulin therapy in Type 2 DM subjects with suboptimal glycemic control.Keywords
This publication has 26 references indexed in Scilit:
- Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN TrialCurrent Diabetes Reports, 2013
- Effect of systemic medications on onset and progression of diabetic retinopathyNature Reviews Endocrinology, 2010
- Prevalence of Diabetic Retinopathy in IndiaOphthalmology, 2009
- Glucolipotoxicity: Fuel Excess and β-Cell DysfunctionEndocrine Reviews, 2008
- Long-standing, insulin-treated type 2 diabetes patients with complications respond well to short-term resistance and interval exercise trainingEuropean Journal of Endocrinology, 2008
- Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1α and VEGFJournal of Clinical Investigation, 2002
- United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet TherapyAnnals of Internal Medicine, 1998
- High Systolic Blood Pressure Increases Prevalence and Severity Of Retinopathy in NIDDM PatientsDiabetes Care, 1992
- Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic controlJournal of Diabetes and its Complications, 1992
- EFFECT OF 1 YEAR OF NEAR-NORMAL BLOOD GLUCOSE LEVELS ON RETINOPATHY IN INSULIN-DEPENDENT DIABETICSThe Lancet, 1983